The Full-Body Scanners Will See You NowRead Now

The supplement stacks of 11 founders and investors. Photos courtesy of subjects.
The supplement stacks of 11 founders and investors. Photos courtesy of subjects.

The Supplement Stacks: All the Pills, Powders and Potions Filling Tech’s Kitchen Counters

The tech elite are going all in on health supplements—and not always with a doctor’s oversight. We asked eleven supplement takers to show us their supply.

The supplement stacks of 11 founders and investors. Photos courtesy of subjects.
Feb. 3, 2023 9:00 AM PST

When Courtney Reum wakes up in his Los Angeles home, it’s time to freeze, shake and dangle upside down. The co-founder of venture firm M13 takes a dip in his cold plunge—shocking his system awake—before stepping onto his Bulletproof vibration plate, which shakes him, getting his blood flowing. His morning routine crescendos into a batlike state as he hangs upside down for 2 minutes on his inversion table.

Reum also has a less arduous morning task—taking his supplements. The investor, who played soccer through college, still treats his body as an elite athlete might, spending anywhere from $300 to $800 a month on supplements of all types. It’s a small price to pay for health, he says, pointing out that LeBron James reportedly spends over a million dollars a year taking care of his body. “I’m obviously not LeBron James but I value peak performance,” he said. (He’s also no stranger to celebrity: His sister-in-law is Paris Hilton and his girlfriend is model Marcela Braga.)

Reum isn’t alone in his commitment to his supplement stack. Anywhere you find entrepreneurs, investors and others of the techie persuasion, you’ll find medicine cabinets filled with collagen pills, creatine powders and fish oils. The tech world has always been obsessed with experimental health treatments: Steve Jobs famously was a fruitarian. Ray Kurzweil, promoter of the singularity, supposedly takes 250 supplements a day. And more recently, biohacking poster child Bryan Johnson proclaimed to Bloomberg that he spends $2 million a year to reverse aging in his body. (Johnson walks us through his supplement regimen below.)

But with venture capitalists pouring over $430 million into supplement startups last year—more than four times what they invested in the space in 2016, according to PitchBook—we’ve entered a new era of self-experimentation. Anecdotally, it’s hard to find an investor or founder who hasn’t at least dabbled in vitamin IVs or isn’t taking a handful of nutritional pills each morning.

To get a deeper sense of all the self-medicating going on, we asked 11 tech leaders to walk us through the multitude of vitamins and supplements they’re using to tweak their bodies from the inside out. In true Silicon Valley fashion, the choices often veer toward the extreme and experimental: Several people take diabetes pills co-opted for weight loss; others experiment with spermidine—a compound originally found in semen—to slow aging; and nootropics, which adherents boldly claim improve cognitive function, are now as commonplace as Advil. Some of the most popular pills and powders are backed by peer-reviewed science—others, not so much.

Get access to exclusive coverage
Read deeply reported stories from the largest newsroom in tech.
Latest Articles
Exclusive asia venture capital
Revenue at TikTok Owner ByteDance Rose More Than 30% in 2022, Topped $80 Billion
TikTok CEO Shou Zi Chew. Photo by Bloomberg
ByteDance, the Chinese owner of TikTok, generated more than $80 billion in annual revenue last year, up more than 30% from roughly $60 billion in 2021, according to two people with knowledge of the figure. The 2022 result, which hasn’t previously been reported, is significant because most technology companies with that kind of revenue experienced a marked slowdown in growth last year. It...
Latest Briefs
Twitter Releases Ranking Source Code Ahead of Verified-Check Removals
Meta Tells Managers to Temporarily Stop Hiring Remote Workers
Fidelity Marks Down Twitter Stake Another 7.9%
Stay in the know
Receive a summary of the day's top tech news—distilled into one email.
Access on the go
View stories on our mobile app and tune into our weekly podcast.
Join live video Q&A’s
Deep-dive into topics like startups and autonomous vehicles with our top reporters and other executives.
Enjoy a clutter-free experience
Read without any banner ads.
From left, Alphabet CEO Sundar Pichai, DeepMind CEO Demis Hassabis and Google Brain chief Jeff Dean. Photos by Getty, Bloomberg
Exclusive google ai
Alphabet’s Google and DeepMind Pause Grudges, Join Forces to Chase OpenAI
OpenAI’s success in overtaking Google with an artificial intelligence–powered chatbot has achieved what seemed impossible in the past: It has forced the two AI research teams within Google’s parent, Alphabet, to overcome years of intense rivalry to work together.
Art by Clark Miller.
Opinion startups
Don’t Build the Wrong Kind of AI Business
At a catch-up coffee a few weeks ago, a founder friend asked me, “What AI thing should we build?” It was the third time that week a founder had asked me the same question.
Orlando Bravo, co-founder of Thoma Bravo LLC. Photo by Bloomberg.
DEALS enterprise
Private Equity Firms’ Secret Weapon for Big Software Buyouts
When Thoma Bravo was drawing up the financing of its $8 billion acquisition of Coupa Software last year, the private equity giant didn’t turn to a bank, and it didn’t get a traditional loan.
Art by Clark Miller.
Market Research e-commerce culture
The Skin-Tech Devices Helping Execs Beautify in a Hurry
I’m always 29 at heart,” said Liyia Wu, CEO of ShopShops, a livestream shopping app for fashion, beauty and lifestyle products.
Art by Clark Miller.
Opinion entertainment media/telecom
The Streaming Business Model Is Hitting Its Half-Life
Sign up for Rosen’s newsletter, Parqor, part of The Information’s newsletter network.
Org Charts microsoft ai
The People Who Make OpenAI Run Fast
Sam Altman has been the face of OpenAI as it quickly outmaneuvered rivals such as Google to launch cutting-edge artificial intelligence to the public.